Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 94 of 100
Features
ECB peps markets and JPMorgan shareholders vote on Dimon’s pay–5 things to know today
By
Laura Lorenzetti
May 19, 2015
Features
The pharma M&A party is still in full swing, as Endo snaps up Par
By
Geoffrey Smith
May 18, 2015
Tech
GlaxoSmithKline plans to work with U.S. scientists to develop a cure for AIDS
By
Reuters
May 11, 2015
Finance
Biopharma deals are booming this year with no end in sight
By
Laura Lorenzetti
May 8, 2015
Features
Cancer drug spending hit $100 billion in 2014. Here’s why it’ll soon be much higher
By
Laura Lorenzetti
May 8, 2015
Features
J&J brings in ethicists to judge on requests for experimental drugs
By
Reuters
May 7, 2015
Tech
Drugmaker Alexion boosts its rare drug pipeline with $8.4 billion deal
By
Reuters
May 6, 2015
Features
Baltimore riots, Google, and Twitter earnings — 5 things to know today
By
Laura Lorenzetti
April 28, 2015
Leadership
How new blood in Washington, DC could impact the marijuana industry
By
Tom Huddleston Jr.
April 24, 2015
Finance
Mylan plays monkey-in-the-middle of hostile takeover battles
By
Jen Wieczner
April 22, 2015
Finance
Teva offers to buy rival Mylan for $40 billion to create generics giant
By
Laura Lorenzetti
April 21, 2015
Features
EU goes after Gazprom, and Teva eyes Mylan — 5 things to know today
By
Laura Lorenzetti
April 21, 2015
Tech
How one company is using artificial intelligence to develop a cure for cancer
By
Cyrus Sanati
April 16, 2015
Features
Americans spent a record amount on medicine in 2014
By
TIME
April 14, 2015
Finance
Hospira hit with further FDA scrutiny after $17 billion Pfizer deal
By
Laura Lorenzetti
April 8, 2015
Most Popular
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House post
By
Eleanor Pringle
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’
By
Emma Burleigh
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the board
By
Jim Edwards